Patents by Inventor Robert Dorr

Robert Dorr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9704165
    Abstract: Systems and methods for evaluating the effectiveness of social media pages. Users of social media systems review and publish various kinds of content on social media pages, including various messages, audio clips, video clips, polls, web links, etc. A social media page evaluation system hosted on a physical server or a cloud receives a social media page that is to be evaluated, and provides results of an evaluation process. The evaluation process involves processing of various criteria and parameters that characterize engagements and interactions between users of social media pages. Results of an evaluation process include qualitative and quantitative attributes in connection with evaluating the effectiveness of published content on social media pages. Such results are useful for purposes of enriching content in social media pages, resulting in greater network traffic due to increased engagements and interaction among users of social media pages.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: July 11, 2017
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: James V. Anderson, John B. Nolt, Michael J. Strutton, Wenchang Yan, Sriti Kumar, Robert M. Maury, Paul M. Broft, Maria F. Arscott, Nancy M. Lim, Jason C. Reynolds, Joe Kearney, John Schult, Melinda M. Weathers, Chad Estes, Erica M. Stanley, Geoffrey Hom, Gregory K. Dunn, Horace Williams, II, Matt White, Reginald R. Bradford, Andrei Erdoss, Andrew Robert Dorr, Brian Culler
  • Patent number: 8987309
    Abstract: A 2-aryl-pyridylazole compound and derivatives useful in slowing the growth of cancer cells are disclosed. Also disclosed are methods of synthesizing the compound, methods of using pharmaceutical compositions containing the compound as an ingredient to slow the growth of cancer cells, and methods of treating cancer patients with pharmaceutical compositions containing the compound as an ingredient.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: March 24, 2015
    Assignees: The Translational Genomics Research Institute, The Arizona Board of Regents on behalf of the University of Arizona
    Inventors: Robert Dorr, Gary Flynn, Haiyong Han, Laurence Hurley, Arthur Y. Shaw
  • Publication number: 20120136029
    Abstract: A 2-aryl-pyridylazole compound and derivatives useful in slowing the growth of cancer cells are disclosed. Also disclosed are methods of synthesizing the compound, methods of using pharmaceutical compositions containing the compound as an ingredient to slow the growth of cancer cells, and methods of treating cancer patients with pharmaceutical compositions containing the compound as an ingredient.
    Type: Application
    Filed: April 19, 2010
    Publication date: May 31, 2012
    Applicants: UNIVERSITY OF ARIZONA, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Robert Dorr, Gary Flynn, Haiyong Han, Laurence Hurley
  • Publication number: 20110282943
    Abstract: Systems and methods for evaluating the effectiveness of social media pages. Users of social media systems review and publish various kinds of content on social media pages, including various messages, audio clips, video clips, polls, web links, etc. A social media page evaluation system hosted on a physical server or a cloud receives a social media page that is to be evaluated, and provides results of an evaluation process. The evaluation process involves processing of various criteria and parameters that characterize engagements and interactions between users of social media pages. Results of an evaluation process include qualitative and quantitative attributes in connection with evaluating the effectiveness of published content on social media pages. Such results are useful for purposes of enriching content in social media pages, resulting in greater network traffic due to increased engagements and interaction among users of social media pages.
    Type: Application
    Filed: May 11, 2011
    Publication date: November 17, 2011
    Applicant: VITRUE, INC.
    Inventors: James V. Anderson, John B. Nolt, Michael J. Strutton, Wenchang Yan, Sriti Kumar, Robert M. Maury, Paul M. Broft, Maria F. Arscott, Nancy M. Lim, Jason C. Reynolds, Joe Kearney, John Schult, Melinda M. Weathers, Chad Estes, Erica M. Stanley, Geoffrey Hom, Gregory K. Dunn, Horace Williams, II, Matt White, Reginald R. Bradford, Andrei Erdoss, Andrew Robert Dorr, Brian Culler
  • Publication number: 20110059719
    Abstract: A portable emergency call device has a single activation button to establish two way communications with an emergency call center. It is not a standard telephone and does not receive any incoming calls and can place outgoing calls only to the designated emergency call center. There is an advantage to making it waterproof.
    Type: Application
    Filed: September 8, 2009
    Publication date: March 10, 2011
    Inventors: Steven Spielvogel, William Robert Dorr
  • Publication number: 20070213354
    Abstract: Compositions and methods for treating multiple sclerosis are disclosed herein. Embodiments of the present invention include methods of treating a multiple sclerosis patient via the administration of a therapeutically effective amount of a composition comprising a compound of the formula: wherein, R1 is heteroalkyl, heterocycloalkyl, or heteroaryl; R2, R4 and R6 are independently hydrogen, halogen, nitro, amino, hydroxy, C1-C6 alkyl, C1-C6 heteroalkyl, heterocycloalkyl or aryl; R3, R5, and R7 are independently hydrogen or C1-C6 alkyl, or R3 and R4 taken together with the carbon atoms to which they are attached form a phenyl ring, or R4 and R5 taken together with the carbon atoms to which they are attached form a phenyl ring, or R5 and R7 taken together with the carbon atoms to which they are attached form a phenyl ring; and n1 and n2 are independently 0, 1 or 2; or a pharmaceutically acceptable salt, a prodrug, or a mixture thereof.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 13, 2007
    Applicant: AmpliMed Corporation
    Inventors: Robert Dorr, Evan Hersh, David Alberts
  • Patent number: 7117483
    Abstract: A debugging framework that exposes debug data in a standardized rowset format such that a relational database engine may be utilized to analyze the data. Conventional high-level scripting languages may be used to generate scripts for reuse and in extracting the debug data. An OLE-DB provider facilitates the query and analysis of debugging information through the database engine.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: October 3, 2006
    Assignee: Microsoft Corporation
    Inventors: Robert A. Dorr, Robert G. Ward, Jr., Keith A. Elmore
  • Publication number: 20050234812
    Abstract: A method is disclosed herein for displaying time lapse for an on-line auction for an item in a computer. According to the method, the processor time in the computer is obtained and compared to the official auction time for the items being auctioned in the on-line auction which is obtained from the on-line auction service. The users computer compares the obtained processor time to the obtained official auction time and correlates the end of time from the on-line auction service to a processor end of time which corresponds to the user's time. The computer then displays the time left correlated to the processor's time preferably in a visual countdown graphical icon.
    Type: Application
    Filed: June 14, 2005
    Publication date: October 20, 2005
    Inventor: Robert Dorr
  • Publication number: 20050176696
    Abstract: The present invention provides compositions useful in treating cancer. The compositions include a synergistic combination of an antineoplastic thiol-binding mitochondrial oxidant with an antineoplastic nucleic acid binding agent, an antineoplastic antimetabolite base analog, or docetaxel. Also provided are methods of assaying the synergistic effects of the combinations and methods of treating cancer using the synergistic combinations.
    Type: Application
    Filed: December 8, 2004
    Publication date: August 11, 2005
    Applicant: Regents of the University of Arizona
    Inventors: Robert Dorr, David Alberts, Evan Hersh
  • Publication number: 20050142078
    Abstract: A method of stimulating the production of melanin by the pigment-producing cells (keratinocytes and/or melanocytes) of the skin, in particular for the induction of skin tanning in humans, comprises administering alpha-MSH or an alpha-MSH analogue and exposing the skin to ultraviolet irradiation.
    Type: Application
    Filed: February 25, 2003
    Publication date: June 30, 2005
    Inventors: Robert Dorr, Norman Levine, Gregory Ertl, David Alberts
  • Publication number: 20040210872
    Abstract: A debugging framework that exposes debug data in a standardized rowset format such that a relational database engine may be utilized to analyze the data. Conventional high-level scripting languages may be used to generate scripts for reuse and in extracting the debug data. An OLE-DB provider facilitates the query and analysis of debugging information through the database engine.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 21, 2004
    Inventors: Robert A. Dorr, Robert G. Ward, Keith A. Elmore
  • Patent number: 5049547
    Abstract: A pharmaceutically active composition comprising a pharmaceutically acceptable carrier and one or more alpha-MSH or analogues thereof for use in the stimulation of integumental melanocytes in vertebrates in order to bring about the production of melanin is disclosed.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: September 17, 1991
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody
  • Patent number: 4918055
    Abstract: A method for stimulating integumental melanocytes by the topical application of alpha-MSH analogs, and compositions comprising said analogs for use in the method are described.
    Type: Grant
    Filed: February 11, 1988
    Date of Patent: April 17, 1990
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine
  • Patent number: 4866038
    Abstract: A method for stimulating integumental melanocytes by the topical application of alpha-MSH analogs, and compositions comprising said analogs for use in the method are described.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: September 12, 1989
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody
  • Patent number: D636371
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: April 19, 2011
    Inventors: Steven Spielvogel, William Robert Dorr